DARMSTADT, Germany & NEW YORK - Wednesday, November 4th 2015 [ME NewsWire] Trial marks second Phase III study of avelumab in non-small cell lung cancer (NSCLC) initiated by Merck and Pfizer in just over six months Primary endpoint is progression-free survival in previously untreated patients with recurrent or Stage IV programmed death-ligand 1 positive (PD-L1+) NSCLC (BUSINESS WIRE)-- Not intended for UK-based media Merck and Pfizer today announced the initiation of an international Phase III study of the investigational cancer immunotherapy avelumab* in a treatment naïve advanced NSCLC setting. The study, JAVELIN Lung 100, is designed to assess the safety and efficacy of avelumab compared with platinum-based doublet chemotherapy, in patients with late-stage NSCLC who have not previously received any treatment for their systemic lung cancer. Avelumab (previously known as MSB0010718C) is an investigational fully human anti-PD-L1 IgG1 monoclonal antibody that potentially uses the bo ... Read more »

PARIS - Samedi 7 Novembre 2015 [ME NewsWire] (BUSINESS WIRE)--Le Groupe TRIGO, prestataire international de services de gestion de la qualité industrielle, basé à Paris, et The PIC group (PIC), acteur numéro un de ce marché en Amérique du Nord, avec un siège à Toronto, se rapprochent pour créer le leader mondial des services d’inspection et d’ingénierie qualité pour les industries automobile et aéronautique. Ce rapprochement entre acteurs de référence sur leur marché donne naissance à un spécialiste incontournable des solutions de gestion opérationnelle de la qualité industrielle, fort de plus de 200 M€ de chiffre d’affaires, d’une solidité financière unique sur son marché, d’un savoir-faire et d’une expertise reconnue pour accompagner les plus grands industriels des secteurs de l’automobile et de l’aéronautique dans leur expansion internationale. Après les acquisitions de Qualitaire, devenu TRIGO QUALITAIRE, (Toulouse, Nantes – France) en 2012 et de GlobalQ, devenu TRIGO GLOBALQ, ( ... Read more »

COLOMBES, France - Friday, November 6th 2015 [ME NewsWire] (BUSINESS WIRE)-- Oberthur Technologies (OT), a leading global provider of embedded security software products, services and solutions, today announced that it will present its third quarter 2015 financial results to investors on Tuesday, November 10th, 2015. Didier Lamouche (CEO) and Anne-France Laclide (CFO) will be presenting these financial results and taking questions the same day at 2.30 p.m. Paris Time (1.30 p.m. London Time/8.30 a.m. New York Time). In order to access the conference call dial-in details, you need to register with Investors Relations: investors@oberthur.com. If you have already registered, details are available on our website: http://investors.oberthur.com. ABOUT OBERTHUR TECHNOLOGIES OT is a world leader in embedded digital security that protects you when you connect, authenticate or pay. OT is strategically positioned in high growth markets and offers embedded security software solutions for “en ... Read more »

PARIS - Wednesday, November 4th 2015 [ME NewsWire] (BUSINESS WIRE)-- The TRIGO Group, an international provider of operational quality solutions headquartered in Paris, France, and The PIC Group, a North American leader of 3rd party quality solutions, have joined forces. The PIC Group, headquartered out of Ontario Canada with locations in Canada, USA, and Mexico, has been servicing the automotive and manufacturing industries for over 30 years. The merger between the two companies will create the largest and most comprehensive breadth of quality services being offered globally in the market today. As these two market leaders merge, a single global provider of quality services will be created with geographic coverage second to none. With over $230 Million in annual sales, a strong financial balance sheet, and a seasoned workforce recognized for their know-how and expertise in quality systems and controls, they are well positioned to dominate the marketplace internationally. Their globa ... Read more »

NATIONAL HARBOR, dans le Maryland - Samedi 7 Novembre 2015 [ME NewsWire] (BUSINESS WIRE)--Cell Signaling Technology, Inc. (CST), un fournisseur mondial d’anticorps, a annoncé aujourd’hui la publication de 6 nouveaux anticorps monoclonaux (AcM) pour la recherche en immunologie tumorale. L’annonce a été faite au 30e congrès annuel de la Society for Immunotherapy of Cancer (SITC) qui se tient du 4au 8 novembre 2015 à National Harbor, dans le Maryland. CST a publié le PD-L2 (D7U8C) XP®, AcM de lapin #82723 ; le PD-L1 (spécifique au domaine extracellulaire) (E1J2J), AcM de lapin #15165 ; le PD-L1 (405.9A11), AcM de souris #29122 ; le PD-1 (EH33), AcM de souris #43248 ; le TIM-3 (D5D5R) XP®, AcM de lapin #45208 ; et l’IDO (D5J4E), AcM de lapin #86630. Chacun de ces anticorps a été validé conformément aux normes rigoureuses de CST afin de reconnaître sa cible régulatrice immunitaire spécifique par immunohistochimie. Ces anticorps viennent s’ajouter à un portefeuille grandissant de produits ... Read more »

NATIONAL HARBOR, Md. - Thursday, November 5th 2015 [ME NewsWire] (BUSINESS WIRE)-- Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, announced today the release of 6 new monoclonal antibodies (mAb) for tumor immunology research. This announcement was made at the 30th annual meeting of the Society for Immunotherapy of Cancer (SITC) at National Harbor, MD November 4-8th, 2015. CST has released PD-L2 (D7U8C) XP® Rabbit mAb #82723, PD-L1 (Extracellular Domain Specific) (E1J2J) Rabbit mAb #15165, PD-L1 (405.9A11) Mouse mAb #29122, PD-1 (EH33) Mouse mAb #43248, TIM-3 (D5D5R) XP® Rabbit mAb #45208, and IDO (D5J4E) Rabbit mAb #86630. Each of these antibodies has been validated according to CST’s stringent standards to recognize their specific immune regulatory target by immunohistochemistry. These antibodies add to a growing portfolio of tumor immunology products that includes the first to market, human-specific, IHC-approved VISTA (D1L2G™) XP® Rabbit mAb #64953, as ... Read more »